A proposed bill in Tallahassee that would require EpiPen and anaphylaxis training for some schools is being heard in its final Senate committee Monday afternoon.

A small trial in adults showed oral immunotherapy for peanut allergy allowed two-third of participants to tolerate up to 5 ...

The Collaborative will focus on equipping early childcare leaders with the knowledge and tools to recognize and respond to ...

Aquestive Therapeutics (AQST) announced positive topline results from its pediatric study for Anaphylm sublingual film in patients aged seven ...

Blue Cross is requiring at-home injection for severe asthma drugs in five states, raising concerns among doctors and patients ...

In February, the FDA approved the Odactra tablet, a sublingual immunotherapy, to treat house dust mite-induced allergic ...

If your child has just been diagnosed with a food allergy, you'll want to learn the basics of everything proper home ...

If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in ...

Blue Cross Blue Shield mandates severe asthma patients self-administer drugs at home, unless their provider gets prior approval from the company.

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...